You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VCN-01

Showing 1 - 25 of 890
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma, Metastatic Trial in Spain, United States (Nab-paclitaxel, Gemcitabine, VCN-01)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Metastatic
  • New York, New York
  • +7 more
Jan 3, 2023

Pancreatic Cancer, Serous Ovarian Cancer Trial in Philadelphia (VCN-01, huCART-meso Cells)

Recruiting
  • Pancreatic Cancer
  • Serous Ovarian Cancer
  • VCN-01
  • huCART-meso Cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 17, 2022

Head and Neck Tumors, Carcinoma, Squamous Cell of Head and Neck, Metastasis Trial in Hospitalet de Llobregat, Barcelona (VCN-01,

Active, not recruiting
  • Head and Neck Neoplasms
  • +3 more
  • VCN-01
  • Durvalumab
  • Hospitalet de Llobregat, Barcelona, Spain
  • +1 more
Mar 25, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors, Pancreatic Adenocarcinoma Trial in Barcelona, Hospitalet De Llobregat,

Completed
  • Locally Advanced Solid Tumors
  • +2 more
  • VCN-01
  • +2 more
  • Barcelona, Spain
  • +4 more
Oct 7, 2020

Fabry Disease Who Received Lentiviral Gene Therapy in Study

Enrolling by invitation
  • Fabry Disease
  • Safety and Efficacy Assessments
  • Melbourne, Parkville VIC, Australia
  • +2 more
Oct 5, 2022

Fabry Disease Trial in Australia, Brazil, United States (AVR-RD-01)

Terminated
  • Fabry Disease
  • Hackensack, New Jersey
  • +4 more
Nov 15, 2022

Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in L'Hospitalet De Llobregat, Madrid (VCN-01, Gemcitabine,

Completed
  • Pancreatic Adenocarcinoma
  • Metastatic Pancreatic Adenocarcinoma
  • VCN-01
  • +2 more
  • L'Hospitalet De Llobregat, Barcelona, Spain
  • +2 more
Sep 27, 2018

Parkinson's Disease Trial (Varenicline)

Completed
Has Results
  • Parkinson's Disease
  • (no location specified)
Jan 25, 2021

a-thalassemia Trial in Nanning (a-globin restored autologous hematopoietic stem cells)

Recruiting
  • α-thalassemia
  • α-globin restored autologous hematopoietic stem cells
  • Nanning, Guangxi, China
    PLA Joint Logistic Support Force No. 923 Hospital
May 6, 2023

Transfusion Dependent Beta-Thalassemia Trial in Nanning (GMCN-508B (LentiRed))

Recruiting
  • Transfusion Dependent Beta-Thalassemia
  • GMCN-508B (LentiRed)
  • Nanning, Guangxi, China
    The affiliated hospital of guangxi medical university
Feb 28, 2023

Porto-Venous Radiomics in Pancreatic Cancer

Recruiting
  • Pancreatic Cancer
  • Non-Interventional
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Jan 17, 2023

Healthy Trial in Adelaide (TR-01-XRR (1), TR-01-XRR (2), TR-01-XRR (3))

Not yet recruiting
  • Healthy
  • TR-01-XRR (1)
  • +6 more
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Feb 3, 2023

Outcome of GI Cancer in NCKUH

Completed
  • Collection of Real-world Data in a Single Institute
    • Tainan, Taiwan
    • +1 more
    Jan 17, 2023

    Email Reminders on No-Show Rates for Appointments inUrology

    Recruiting
    • No-Show Patients
    • Reminder Systems
    • E-Mail Reminder
    • Caba, Argentina
      Hospital Italiano de Buenos
    Nov 2, 2023

    COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)

    Recruiting
    • COVID-19
    • +3 more
    • RQ-001
    • Placebo
    • Cullman, Alabama
    • +8 more
    Sep 28, 2023

    Joint Pain Trial in Mumbai, Nashik, Panvel (E-PR-01 (Low dose), E-PR-01 (High Dose), Placebo)

    Not yet recruiting
    • Joint Pain
    • E-PR-01 (Low dose)
    • +2 more
    • Mumbai, Maharashtra, India
    • +3 more
    Apr 24, 2023

    Chronic Pain Trial (ST-01, 1% Lidocaine HCL)

    Not yet recruiting
    • Chronic Pain
    • (no location specified)
    Jan 27, 2023

    Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

    Active, not recruiting
    • Hemophilia B
    • AAV5-hFIX
    • Berlin, Germany
    • +5 more
    Jan 17, 2023

    Adenosine Deaminase Deficiency, Severe Combined Immunodeficiencies (SCID) Trial in London (genetic, other, drug)

    Completed
    Has Results
    • Adenosine Deaminase Deficiency
    • Severe Combined Immunodeficiencies (SCID)
    • Infusion of autologous EFS-ADA LV CD34+ cells
    • +3 more
    • London, United Kingdom
      Great Ormond Street Hospital for Children NHS Foundation Trust
    Aug 20, 2021

    How do Perceptions of Coronavirus Disease Risk Influence Health

    Recruiting
    • Pregnancy Related
      • Vancouver, British Columbia, Canada
      • +1 more
      Jan 9, 2023

      Cancer Patient Perspectives During COVID-19

      Active, not recruiting
      • Breast Cancer
        • Aurora, Colorado
          Colorado Research Center
        Nov 17, 2022

        Adverse Events Trial in United States (Irrisept, Standard of Care)

        Completed
        • Adverse Events
        • Irrisept
        • Standard of Care
        • Tucson, Arizona
        • +16 more
        May 4, 2022

        Relative Dose Intensity of Adjuvant Chemotherapy in Older ER+

        Not yet recruiting
        • Breast Cancer
          • (no location specified)
          Aug 21, 2023

          Telomere Biology Disorders With Bone Marrow Failure Trial in Cincinnati (EXG34217)

          Not yet recruiting
          • Telomere Biology Disorders With Bone Marrow Failure
          • EXG34217
          • Cincinnati, Ohio
            Cincinnati Children's Hospital
          May 18, 2023

          Hernia, Inguinal Trial in Salt Lake City (local anaesthetic injection)

          Recruiting
          • Hernia, Inguinal
          • local anaesthetic injection
          • Salt Lake City, Utah
            Todd Bertoch
          Apr 14, 2023